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1220An international vascular registry infrastructure for medical
device evaluation and surveillanceyArt Sedrakyan, MD, PhD,a Jack L. Cronenwett, MD,b Maarit Venermo, MD, PhD,c Larry Kraiss, MD,d
Danica Marinac-Dabic, MD, PhD,e and Martin Björck, MD, PhD,f New York, NY; Lebanon, NH; Helsinki, Finland;
Salt Lake City, Utah; Silver Spring, Md; and Uppsala, Sweden3The Medical Device Epidemiology Network (MDEpiNet)
is an innovative effort supported by the US Food and
Drug Administration (FDA) that is committed to the
development of a medical device science and surveil-
lance infrastructure. Recently MDEpiNet sponsored a na-
tional medical device registry task force which
developed a guidance document for 21st century medi-
cal device evaluation that highlights the importance of
national and international registries, their linkages with
other relevant data, and stakeholder involvement.1 Two
international efforts, the International Consortium of
Orthopedic Registries (ICOR) and the International
Consortium of Cardiovascular Registries (ICCR)2 were
launched in the past 4 years to study orthopedic and
cardiovascular devices in this regard.
INTERNATIONAL CONSORTIUM OF VASCULAR
REGISTRIES (ICVR)
In November 2014, the MDEpiNet Science & Infrastruc-
ture Center, In collaboration with the Society for Vascular
Surgery Vascular Quality Initiative (SVS/VQI) and the
VASCUNET registry collaboration (a working committee
of the European Society for Vascular Surgery, ESVS,
founded in 1997, including 12 vascular registries frome Department of Healthcare Policy and Research, Weill Cornell Medical
ge, New Yorka; the Department of Surgery, Dartmouth-Hitchcock Med-
enter, Lebanonb; the Department of Vascular Surgery, University of Hel-
and Helsinki University Hospital, Helsinkic; the Division of Vascular
ry, University of Utah, Salt Lake Cityd; the Division of Epidemiology, Of-
f Surveillance and Biometrics, Center for Devices and Radiological
h, FDA, Silver Springe; the Department of Surgical Sciences, Uppsala
rsity, Uppsala.f
per was submitted the same day to the Journal of Vascular Surgery and
uropean Journal of Vascular and Endovascular Surgery, after having
ved permission from the Editor in Chief of both journals to do so.
dy was conducted under the contract from US Food and Drug Admin-
ion (FDA) HHSF22321110172C Advancing the Implementation of Medical
e Surveillance: MDEpiNet Science and Infrastructure Center
edrakyan, principal investigator). The FDA did not control the design
onduct of the work andmanagement but did participate in the analysis
nterpretation of the data as well as the preparation, review, and approval
manuscript, and the decision to submit the manuscript for publication.
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x.doi.org/10.1016/j.jvs.2017.01.020Europe, Australia, and New Zealand) launched the ICVR
to build an innovative network dedicated to vascular sur-
gery and device outcomes. The ICVR has both direct data
sharing bymultiple national registries anddistributed sys-
tems for research and surveillance initially focusing on
high priority questions related to the variation in device
use and patient selection. It has access to data regarding
hundreds of thousands of procedures performed to treat
abdominal, carotid and lower limb arterial disease by
both open and endovascular surgery. Many registries
also have data on venous procedures, such as ileofemoral
venous stents and inferior vena cava ﬁlters. Since 2014, the
representatives of 13 registries have developed a gover-
nance structure for data sharing and held four major
workshops in New York City, Uppsala, Sweden and
Hamburg, Germany, to launch initial investigations.
International sharing of experience in quality improve-
ment, desire to improve vascular care and evaluation of
device performance are the three main motivations that
have led to enthusiastic participation of national registries
and clinician leaders. Importantly, most vascular devices
are approved earlier in Europe than in the United States,
but the United States population provides a larger cohort
for device evaluation. Combining data frommultiple reg-
istries accelerates the ability to detect device safety sig-
nals, to beneﬁt patients worldwide.
CASE STUDY OF DEVICE USE
Initial ICVR studies will address variation in the use of
technology and techniques for carotid disease, abdom-
inal aortic aneurysms (AAAs), and peripheral arterial dis-
ease. Endovascular aneurysm repair (EVAR) for treating
AAAs is an important case study that shows the value
of international data. Since stent grafts were introduced
for treating AAAs they have been increasingly used
because of their less invasive nature and better early out-
comes compared with open surgical repair.4 However,
high device costs and expenses related to post-
implantation surveillance have led to different rates of
utilisation between countries. The recently published
ICVR data5 indicate that while > 70% of patients with
AAA in the United States and Australia are treated by
EVAR, this was the case in < 40% of patients in Norway,
Denmark, and Hungary.
International variation in the use of the EVAR indicates
that there is still uncertainty about its beneﬁt in various
sub-populations of patients.6 The variation also allows
Fig 1. Abdominal aortic aneurysm repairs performed on intact vs ruptured aorta among ICVR participating
countries 2010e2013. (Data from Beck et al.5)
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surgery. A major advantage of international investiga-
tions is the inclusion of a much larger number of
patients, making it possible to study subgroups of
patients, and to assess rare adverse events that are
difﬁcult to study in individual national registries. There
are interesting differences between countries regarding
the proportion of intact AAA repairs, varying from 71% in
Finland to 92% in the United States (Fig 1), as well as the
proportion of AAA repairs performed on patients with
small diameter aneurysms.5
POTENTIAL FOR STAKEHOLDER
COLLABORATION
The ICVR effort includes international registry owners,
as well as manufacturers, the Center for Medicare and
Medicaid Services, and the FDA. This stakeholder
engagement has enabled a discussion not only related
to device innovation and evaluation but also the poten-
tial registry role as an advanced surveillance system.
The stakeholders recognise that the interest in creating
a global registry consortium is sincere and has a substan-
tial potential to make an international impact. From reg-
ulatory and industry perspectives, data from ICVR can be
used for both pre- and post-market purposes including
leveraging the data for labeling changes, creating global
objective performance criteria or adverse event report-
ing, and hosting surveillance studies often required by
regulators. The data can also help develop global risk
prediction models for patient centred decision making.
Finally, ICVR projects can lead to the development of
new intellectual property and conduct of more efﬁcient
international clinical trials that leverage the global regis-
try infrastructure.
The ICOR was the ﬁrst major international initiative
related to implantable devices and developed a modelfor collaboration.7 However, there are major differences
between ICVR and ICOR efforts in terms of scientiﬁc
approach to data collection and aggregation. The
ICOR orthopedic registries are able to evaluate failing
devices within their own registry because device failure
most often leads to re-operations conducted by ortho-
pedic surgeons. When treating AAAs, however, this is
not always the case, since device failure may cause
rupture and death without additional surgery, which is
not captured in the same registry. Hence, one of the
challenges the ICVR is working out how to ensure
long-term follow-up by linking with administrative da-
tabases without coming in conﬂict with data protection
laws in the different countries. Sharing expertise for reg-
istry data linkages with other data sources, such as
cause of death registries, will be an important aspect
of international learning.
ICVR beneﬁts from strong support of registry cham-
pions within each country who recognise the goals and
requirements, and who enthusiastically endorse this
worldwide effort. ICVR also recognised that while com-
mon deﬁnitions need to be adopted for core variables,
the process should be pragmatic and performed simul-
taneously with conduct of projects so that data harmoni-
sation is not disconnected from reality. An important
challenge is uniform device identiﬁcation within regis-
tries. The adoption of unique device identiﬁers (UDIs)8
by manufacturers will enable more device speciﬁc
surveillance efforts.
SUMMARY
Based on the successful template of ICOR, ICVR has
rapidly developed global collaboration with potential
beneﬁts for patients worldwide. It is an innovative effort
building on successes achieved in orthopedics and
cohesion among international registries. ICVR will
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April 2017enable a collaboration of stakeholders to create a sus-
tainable global system to evaluate the safety and efﬁ-
cacy of new and existing vascular devices and
procedures, while promoting scientiﬁc evaluation, inno-
vation, and quality improvement.
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